Hui Mao

1.0k total citations
41 papers, 789 citations indexed

About

Hui Mao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hui Mao has authored 41 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Hui Mao's work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (5 papers) and Mitochondrial Function and Pathology (3 papers). Hui Mao is often cited by papers focused on MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (5 papers) and Mitochondrial Function and Pathology (3 papers). Hui Mao collaborates with scholars based in China, United States and Taiwan. Hui Mao's co-authors include Fei Pan, Wooi Loon Ng, Jeffrey J. Olson, Dan Yan, Chunhai Hao, Yin‐Yuan Mo, Xiangming Zhang, Zhaobin Zhang, Walter J. Curran and Ya Wang and has published in prestigious journals such as Nature, PLoS ONE and Scientific Reports.

In The Last Decade

Hui Mao

41 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui Mao China 15 552 400 144 65 52 41 789
Parvaneh Nikpour Iran 15 444 0.8× 279 0.7× 92 0.6× 49 0.8× 65 1.3× 72 666
Ruiyan Li China 14 458 0.8× 299 0.7× 57 0.4× 57 0.9× 40 0.8× 22 689
Zheying Zhang China 15 658 1.2× 551 1.4× 96 0.7× 60 0.9× 49 0.9× 30 860
Ada Girnita Sweden 16 563 1.0× 195 0.5× 164 1.1× 51 0.8× 41 0.8× 22 823
Chunfa Qian China 15 365 0.7× 263 0.7× 85 0.6× 81 1.2× 25 0.5× 34 632
Shuangyin Han China 18 733 1.3× 300 0.8× 159 1.1× 42 0.6× 55 1.1× 29 976
Laurence Lasorsa France 7 369 0.7× 176 0.4× 136 0.9× 54 0.8× 33 0.6× 7 580
Valeriana Cesarini Italy 15 493 0.9× 166 0.4× 115 0.8× 59 0.9× 36 0.7× 25 706
Limin Sun China 15 446 0.8× 179 0.4× 287 2.0× 63 1.0× 52 1.0× 28 729

Countries citing papers authored by Hui Mao

Since Specialization
Citations

This map shows the geographic impact of Hui Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Mao more than expected).

Fields of papers citing papers by Hui Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Mao. The network helps show where Hui Mao may publish in the future.

Co-authorship network of co-authors of Hui Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Mao. A scholar is included among the top collaborators of Hui Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Mao. Hui Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yanjun, Rong Gao, Zhihua Wu, et al.. (2025). Complete biosynthesis of salicylic acid from phenylalanine in plants. Nature. 645(8079). 218–227. 11 indexed citations
2.
Yang, Yuan, Xiaoke Zhang, Weizhi Chen, et al.. (2025). Topological Scaffold‐Based Trispecific Recombinant Protein‐Drug Conjugates for Solid Tumor Eradication. Advanced Science. 12(37). e01093–e01093. 1 indexed citations
3.
Li, Xiaojun, Haoxuan Chen, Jiahui Zhang, et al.. (2024). Risk factors of neuropathic pain in multiple sclerosis: a retrospective case-cohort study. Frontiers in Immunology. 15. 1309583–1309583. 3 indexed citations
4.
Mao, Hui, et al.. (2024). Intercellular Mitochondrial Transfer: The Novel Therapeutic Mechanism for Diseases. Traffic. 25(9). e12951–e12951. 5 indexed citations
5.
Han, Liang, et al.. (2023). Antidepressant effects of dexmedetomidine compared with ECT in patients with treatment-resistant depression. Journal of Affective Disorders. 347. 437–444. 3 indexed citations
6.
8.
Yu, Ting, Lingyu Ran, Hongwen Zhao, et al.. (2021). Circular RNA circ-TNPO3 suppresses metastasis of GC by acting as a protein decoy for IGF2BP3 to regulate the expression of MYC and SNAIL. Molecular Therapy — Nucleic Acids. 26. 649–664. 63 indexed citations
9.
Liu, Lingling, et al.. (2020). A Network Pharmacology Approach to Investigate the Active Compounds and Mechanisms of Musk for Ischemic Stroke. Evidence-based Complementary and Alternative Medicine. 2020(1). 4063180–4063180. 21 indexed citations
10.
Wang, Lina, Jie Lin, Ting Yu, et al.. (2020). Identification of plasma miR-106a-5p and miR-30a-5p as potential biomarkers for mesangial proliferative glomerulonephritis. Clinical Biochemistry. 84. 79–86. 5 indexed citations
11.
Lin, Jie, Wěi Li, Ting Yu, et al.. (2019). Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer. Clinical Biochemistry. 74. 60–68. 73 indexed citations
12.
Mao, Hui, Fei Pan, Zhi‐Yong Wu, et al.. (2017). CD19 lo CD27 hi Plasmablasts Suppress Harmful Th17 Inflammation Through Interleukin 10 Pathway in Colorectal Cancer. DNA and Cell Biology. 36(10). 870–877. 12 indexed citations
13.
Shi, Yan, Yanrong Wang, Yao Lv, et al.. (2017). KRAS mutation and primary tumor location do not affect efficacy of bevacizumab-containing chemotherapy in stagae IV colorectal cancer patients. Scientific Reports. 7(1). 14368–14368. 13 indexed citations
14.
Shi, Hui, Hanru Ren, Xiaojing Yang, et al.. (2015). Overexpression of activator of G-protein signaling 3 decreases the proliferation of esophageal squamous cell carcinoma. Pathology - Research and Practice. 211(6). 449–455. 7 indexed citations
15.
Mao, Hui, Jiao Liu, Jian Xu, et al.. (2013). Dynamic change of SGK expression and its role in neuron apoptosis after traumatic brain injury.. PubMed. 6(7). 1282–93. 23 indexed citations
16.
Mao, Hui, Jiao Liu, Wei Shi, et al.. (2013). The Expression Patterns of Septin-9 After Traumatic Brain Injury in Rat Brain. Journal of Molecular Neuroscience. 51(2). 558–566. 3 indexed citations
17.
Chen, Jian, Hui Mao, Lanchun Ni, et al.. (2013). SCY1-like 1 binding protein 1 (SCYL1-bp1) interacts with p53-induced RING H2 protein (Pirh2) after traumatic brain injury in rats. Journal of Molecular Histology. 44(3). 271–283. 3 indexed citations
18.
Xu, Jian, Jianhua Cao, Hui Mao, et al.. (2012). Different Functions of HIPK2 and CtBP2 in Traumatic Brain Injury. Journal of Molecular Neuroscience. 49(2). 395–408. 19 indexed citations
19.
Zhang, Jinlong, Debao Li, Aiguo Shen, et al.. (2012). Expression of RBMX After Spinal Cord Injury in Rats. Journal of Molecular Neuroscience. 49(2). 417–429. 22 indexed citations
20.
Chen, Jian, Hui Mao, Wei Jin, et al.. (2012). Up-regulation of ski-interacting protein in rat brain cortex after traumatic brain injury. Journal of Molecular Histology. 44(1). 1–10. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026